Actively Recruiting
Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension
Led by Chinese University of Hong Kong · Updated on 2025-12-10
364
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate whether patients assigned to the telemedicine (HealthCap) group demonstrate non-inferior blood pressure (BP) control compared to patients in the usual care group at 12 months. The main question it aims to answer is: * Do participants in telemedicine group have non-inferior daytime ambulatory blood pressure readings at 12-month, compared to usual care group? * Do participants in telemedicine group have better HT treatment, higher self-efficacy, reduced number of visits to primary care clinics and similar health care utilisation other than GOPCs, compared to usual care group? Participant in telemedicine group will: * Receive reminders to measure 7-day home blood pressure before their index consultation. * Get their drug refilled automatically as well as have consultations deferred 16-18 weeks later, if their blood pressure is under optimal control. * Have consultations as scheduled, if their BP is suboptimal or any of the safety questions screen positive. Participants in control group will: * Have consultation with physicians every 16-18 weeks.
CONDITIONS
Official Title
Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of essential hypertension
- Currently taking anti-hypertension medications
- Well-controlled hypertension based on out-of-office blood pressure measurements (home or ambulatory)
- Can read basic Chinese used in the HealthCap app
- Have used any mobile app (non-hypertension related) in the past year
- Aged between 18 and 80 years
You will not qualify if you...
- Unable to provide informed consent
- Unwilling to perform home blood pressure monitoring or repeated ambulatory measurements
- Relative contraindications to ambulatory blood pressure monitoring (e.g., atrial fibrillation, night shift work, occupational driving, bleeding disorders)
- Severe mental illness impairing use of HealthCap (e.g., schizophrenia, dementia, active suicidal risk)
- Acute or chronic diseases requiring regular physical assessments or medication changes (e.g., poorly controlled diabetes, depression needing medication, active cancer)
- Predicted life expectancy less than 1 year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
HKW and NTEC GOPC
Hong Kong, Hong Kong, Hong Kong
Actively Recruiting
Research Team
K
Kam Pui Lee
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here